.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Julphar
Accenture
QuintilesIMS
Johnson and Johnson
Fuji
Chubb
Cipla
Queensland Health
Fish and Richardson

Generated: July 20, 2017

DrugPatentWatch Database Preview

Tobramycin sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tobramycin sulfate and what is the scope of tobramycin sulfate freedom to operate?

Tobramycin sulfate
is the generic ingredient in four branded drugs marketed by Teva Pharms Usa, Lilly, Mylan Labs Ltd, Hospira, West-ward Pharms Int, X Gen Pharms, Igi Labs Inc, Fresenius Kabi Usa, Apothecon, Watson Labs Inc, Claris, Akorn, and Xellia Pharms Aps, and is included in thirty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for tobramycin sulfate. Nine suppliers are listed for this compound.

Summary for Generic Name: tobramycin sulfate

Tradenames:4
Patents:1
Applicants:13
NDAs:31
Drug Master File Entries: see list18
Suppliers / Packagers: see list9
Bulk Api Vendors: see list68
Clinical Trials: see list723
Patent Applications: see list7,127
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tobramycin sulfate at DailyMed

Pharmacology for Ingredient: tobramycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
NEBCIN
tobramycin sulfate
INJECTABLE;INJECTION062008-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Igi Labs Inc
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063122-001Oct 31, 1994DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION065122-002Nov 29, 2002APRXNoYes► Subscribe► Subscribe
Apothecon
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION064026-001May 31, 1994DISCNNoNo► Subscribe► Subscribe
Igi Labs Inc
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063120-001Oct 31, 1994DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Queensland Health
Cerilliant
Federal Trade Commission
Merck
Citi
Argus Health
Julphar
Dow
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot